Morgan Wolfe, 40, from Aurora, Colorado, received the Johnson & Johnson vaccine on April 1
One week later, she began experiencing a headache, dizziness, fatigue, chills and changes to her vision
Wolfe went to the ER 12 days later, where CT scans show blood clots in her brain and her lungs
On the same day, the CDC and FDA recommended a pause of the J&J vaccine following blood clot concerns
After the CDC warned that the blood clotting medication heparin could make the condition worse, doctors tried an alternative called bivalirudin
The medication worked and Wolfe was discharged from the hospital six days later
New treatment used to care for Denver woman who developed blood clots after J&J vaccine
Nearly one in a half million was Morgan Wolfeâs chances of developing blood clots after receiving the Johnson and Johnson vaccine.
and last updated 2021-05-05 11:20:09-04
AURORA, Colo. â Nearly one in a half-million was Morgan Wolfeâs chances of developing blood clots after receiving the Johnson and Johnson COVID-19 vaccine. I m definitely curious as to the cause because itâs a super rare occurrence, said Wolfe.
State health officials tell Denver7 s Gary Brode thereâs been eight reports of blood clotting following the J&J vaccine in Colorado. Wolfe got her shot the first of April. About a week later is when she started feeling the effects.